Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fatigue × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 227 Carcinoma, Intraductal, Noninfiltrating 20 Breast Carcinoma In Situ 17 Neoplasm Metastasis 12 Neoplasms 11 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Breast Cancer Female 4 Prostatic Neoplasms 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Astrocytoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1

Interventions

Exercise 28 Therapeutics 21 Yoga 16 Modafinil 16 Methylphenidate 16 Psychiatric Rehabilitation 10 Acupuncture Therapy 10 Surveys and Questionnaires 9 Educational Status 8 Cognitive Behavioral Therapy 8 Walking 7 Ultraviolet Therapy 7 Early Intervention, Educational 7 Control Groups 7 Physical Therapy Modalities 6 Exercise Therapy 6 Acceptance and Commitment Therapy 6 Therapeutic Touch 5 Counseling 5 Palliative Care 4 Methods 4 Epoetin Alfa 4 Dexamethasone 4 Behavior Therapy 4 Touch 3 Sugars 3 Standard of Care 3 Sodium Chloride 3 Saline Solution 3 Resistance Training 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed

86 enrolled 4 charts

Breast Neoplasms, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡